Inversion Therapeutics

Burlingame, CA · Founded 2025 · Privately Held (backing)

Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. Inversion Therapeutics is based in Burlingame, CA and was founded in 2025. It was valued at $17 million at its seed round in Aug 2025, the last priced event on record. It has raised $6.9 million across 1 recorded round; the latest was a $6.9 million early-stage round in Jun 2025.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$6.9M
Last round
Early Stage VC
Jun 2025

Who backs Inversion Therapeutics?

1 investors
InvestorType
Red Tree Venture CapitalVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Inversion Therapeutics investors

1 investor is on record for Inversion Therapeutics, including Red Tree Venture Capital. By type, the record holds 1 venture capital firm. The early-stage round in Jun 2025 drew 4 investors.

Free account
More of Inversion Therapeutics with a free account
  • ·Watch Inversion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 1 firms already write checks for companies like Inversion Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View